Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenetics Modifications in Morbid Obesity and Obstructive Sleep Apnea Patients (EPIMOOSA): Continous Positive Airway Pressure (CPAP) and Bariatric Surgery Impact. EPIMOOSA Study

NCT03995836 is registered in ClinicalTrials.gov with Aragon Institute of Health Sciences as lead sponsor.

NCT NCT03995836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03995836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenetics Modifications in Morbid Obesity and Obstructive Sleep Apnea Patients (EPIMOOSA): Continous Positive Airway Pressure (CPAP) and Bariatric Surgery Impact. EPIMOOSA Study
Lead sponsor
Aragon Institute of Health Sciences
Phase
Observational
Overall status
Completed
Start date
July 1, 2014
Completion date
July 1, 2018
Enrollment
70 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epigenetic disorder, morbid obesity, obstructive sleep apnea